Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCϵ, Stat3, and Epithelial-to-Mesenchymal Transition Markers

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer Prevention Research

• Publication date

  2015-01-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1940-6207.CAPR-14-0231PMID 25627799PMCID PMC4417441
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correction

  2014cited by this paper
• Cyclooxygenase 2 genotypes influence prostate cancer susceptibility in Japanese Men

  2014cited by this paper
• Cyclooxygenase‐2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice

  2014cited by this paper
• The combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivo

  2013cited by this paper
• Plumbagin, a medicinal plant (lumbago zeylanica)‐derived 1,4‐naphthoquinone, inhibits growth and metastasis of human prostate cancer PC‐3M‐luciferase cells in an orthotopic xenograft mouse model

  2013cited by this paper
• Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCε, Stat3 and neuroendocrine markers.

  2012cited by this paper
• Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF‐κB signaling pathways

  2012cited by this paper
• Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLT

  2012cited by this paper
• Slug, a unique androgen-regulated transcription factor, coordinates androgen receptor to facilitate castration resistance in prostate cancer.

  2012cited by this paper
• Interleukin-6: A multifunctional targetable cytokine in human prostate cancer

  2012cited by this paper
• Oral infusion of pomegranate fruit extract inhibits prostate carcinogenesis in the TRAMP model.

  2012cited by this paper
• Activation of Nuclear Factor-Kappa B (NFκB) in Prostate Cancer is Mediated by PKC Epsilon (PKCϵ)

  2012cited by this paper
• Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), isolated from Plumbago zeylanica, inhibits ultraviolet radiation-induced development of squamous cell carcinomas.

  2012influential reference
• Perspectives on medicinal properties of plumbagin and its analogs

  2012cited by this paper
• Microenvironmental regulation of epithelial-mesenchymal transitions in cancer.

  2012influential reference
• Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma.

  2011cited by this paper
• Transgenic overexpression of PKCε in the mouse prostate induces preneoplastic lesions

  2011cited by this paper
• Interleukin-6: a potential biomarker of resistance to multitargeted receptor tyrosine kinase inhibitors in castration-resistant prostate cancer.

  2011cited by this paper
• Soluble interleukin-6 receptor to interleukin-6 (sIL‑6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy.

  2011cited by this paper
• IL-6/IL-6R as a potential key signaling pathway in prostate cancer development.

  2011cited by this paper
• Slug expression enhances tumor formation in a noninvasive rectal cancer model.

  2011cited by this paper
• Plumbagin Inhibits Osteoclastogenesis and Reduces Human Breast Cancer-Induced Osteolytic Bone Metastasis in Mice through Suppression of RANKL Signaling

  2011cited by this paper
• Plumbagin, a novel Nrf2/ARE activator, protects against cerebral ischemia

  2010cited by this paper
• Plumbagin, Isolated from Plumbago zeylanica, Induces Cell Death through Apoptosis in Human Pancreatic Cancer Cells

  2010cited by this paper
• Regulation of Prostate Cancer Cell Survival by Protein Kinase Cϵ Involves Bad Phosphorylation and Modulation of the TNFα/JNK Pathway*

  2010cited by this paper
• Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines

  2010cited by this paper
• Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis.

  2010cited by this paper
• Protein kinase Cε mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression and cell invasion in various human cancer cell lines via integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2)

  2010cited by this paper
• Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers.

  2009cited by this paper
• Predicting survival for men with clinically localized prostate cancer

  2008cited by this paper
• Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer.

  2008cited by this paper
• Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.

  2008cited by this paper
• Protein kinase C epsilon, which sensitizes skin to sun's UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3.

  2007cited by this paper
• Proteome analysis of human androgen‐independent prostate cancer cell lines: Variable metastatic potentials correlated with vimentin expression

  2007cited by this paper
• Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.

  2007cited by this paper
• Blockade of beta-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice.

  2007cited by this paper
• Plumbagin (5-Hydroxy-2-methyl-1,4-naphthoquinone) Induces Apoptosis and Cell Cycle Arrest in A549 Cells through p53 Accumulation via c-Jun NH2-Terminal Kinase-Mediated Phosphorylation at Serine 15 in Vitro and in Vivo

  2006cited by this paper
• Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells

  2006cited by this paper
• Plumbagin (5-Hydroxy-2-methyl-1,4-naphthoquinone) Suppresses NF-κB Activation and NF-κB-regulated Gene Products Through Modulation of p65 and IκBα Kinase Activation, Leading to Potentiation of Apoptosis Induced by Cytokine and Chemotherapeutic Agents*

  2006cited by this paper
• Measurement and pharmacokinetic study of plumbagin in a conscious freely moving rat using liquid chromatography/tandem mass spectrometry.

  2006influential reference
• PKCε‐mediated phosphorylation of vimentin controls integrin recycling and motility

  2005cited by this paper
• Mechanisms of the development of androgen independence in prostate cancer

  2005cited by this paper
• PKCepsilon-mediated phosphorylation of vimentin controls integrin recycling and motility.

  2005cited by this paper
• Chemoprevention by grape seed extract and genistein in carcinogen-induced mammary cancer in rats is diet dependent.

  2004influential reference
• Integrin signaling links protein kinase Cɛ to the protein kinase B/Akt survival pathway in recurrent prostate cancer cells

  2004cited by this paper
• Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate.

  2004cited by this paper
• Protein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells.

  2003cited by this paper
• Overexpression of vimentin: role in the invasive phenotype in an androgen-independent model of prostate cancer.

  2003cited by this paper
• Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model

  2003cited by this paper
• Protein kinase Cɛ interacts with Bax and promotes survival of human prostate cancer cells

  2003cited by this paper
• Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

  2003cited by this paper
• Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma

  2002cited by this paper
• Protein Kinase Cε Has the Potential to Advance the Recurrence of Human Prostate Cancer

  2002cited by this paper
• Protein kinase cepsilon has the potential to advance the recurrence of human prostate cancer.

  2002cited by this paper
• Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol.

  2000cited by this paper
• Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

  1998cited by this paper
• Inhibitory effects of plumbagin and juglone on azoxymethane-induced intestinal carcinogenesis in rats.

  1998cited by this paper
• Alterations in levels of different protein kinase C isotypes and their influence on behavior of squamous cell carcinoma of the oral cavity: εPKC, a novel prognostic factor for relapse and survival

  1995cited by this paper
• Alterations in levels of different protein kinase C isotypes and their influence on behavior of squamous cell carcinoma of the oral cavity: epsilon PKC, a novel prognostic factor for relapse and survival.

  1995cited by this paper
• Effect of plumbagin on some glucose metabolising enzymes studied in rats in experimental hepatoma

  1993cited by this paper
• Effect of testosterone replacement therapy on quantitative spermatogenesis following plumbagin treatment in immature rats.

  1986cited by this paper
• Antifertility activity of Plumbago zeylanica Linn. root.

  1982cited by this paper
• Antifertility activity of Plumbago zeylanica Linn. root.

  1982cited by this paper
• Cancer,Facts and Figures about.

  year unknowncited by this paper

• Harnessing nature's therapeutic potential: A review of natural products in prostate cancer management.

  2025cites this paper
• Different Derivatives of Plumbagin Analogue: Bioavailability and Their Toxicity Studies

  2025cites this paper
• Emerging COX-2 inhibitors-based nanotherapeutics for cancer diagnosis and treatment.

  2024cites this paper
• Comprehensive review on Plumbago indica: Traditional, pharmacological insights and conservation strategies

  2024cites this paper
• Exploring natural resources: Plumbagin as a potent anticancer agent

  2024cites this paper
• Natural STAT3 inhibitors for cancer treatment: A Comprehensive Literature Review.

  2023cites this paper
• Modulation of hypoxia-inducible factor-1 signaling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review

  2023cites this paper
• Plumbago indica L.: A review of its medicinal uses, phytochemistry, pharmacology, and toxicology

  2023cites this paper
• JI017 Induces Cell Autophagy and Apoptosis via Elevated Levels of Reactive Oxygen Species in Human Lung Cancer Cells

  2023cites this paper
• Acid-catalyzed synthesis of 2,3-dihydronaphtho[2,3-b]furan and 3,4-dihydro-2H-benzo[g]chromene derivatives

  2023cites this paper
• Apogossypolone Inhibits Cell Proliferation and Epithelial-Mesenchymal Transition in Cervical Cancer via Activating DKK3

  2022cites this paper
• An in-Depth Analysis of Ovarian Cancer: Pathogenesis and Clinical Manifestation.

  2022cites this paper
• Phytochemistry and Pharmacological Activities of Plumbago indica L.: An Overview

  2022cites this paper
• Propylene Glycol Caprylate-Based Nanoemulsion Formulation of Plumbagin: Development and Characterization of Anticancer Activity

  2022cites this paper
• Regression of Melanoma Following Intravenous Injection of Plumbagin Entrapped in Transferrin-Conjugated, Lipid–Polymer Hybrid Nanoparticles

  2021cites this paper
• PSMA conjugated combinatorial liposomal formulation encapsulating genistein and plumbagin to induce apoptosis in prostate cancer cells.

  2021cites this paper
• In Vitro and In Vivo Anti-Inflammatory Activities of Benjakul: A Potential Medicinal Product from Thai Traditional Medicine

  2020cites this paper
• Plumbagin‐Serum Albumin Interaction: Spectral, Electrochemical, Structure‐Binding Analysis, Antiproliferative and Cell Signaling Aspects with Implications for Anticancer Therapy

  2020cites this paper
• Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing

  2020cites this paper
• 27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6–JAK–STAT3 Signaling in Prostate Cancer Cells

  2020cites this paper
• Potential Applications of NRF2 Modulators in Cancer Therapy

  2020cites this paper
• Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances

  2020cites this paper
• Plumbagin: A potential anti-cancer compound.

  2020cites this paper
• The triphenyltin carboxylate derivative triphenylstannyl 2-(benzylcarbamoyl)benzoate impedes prostate cancer progression via modulation of Akt/FOXO3a signaling.

  2020cites this paper
• Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3.

  2019cites this paper
• Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy.

  2019cites this paper
• DISTINCTIVE REQUIREMENT OF PKCε IN THE CONTROL OF Rho GTPases IN EPITHELIAL AND MESENCHYMALLY-TRANSFORMED LUNG CANCER CELLS

  2019cites this paper
• Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer.

  2019cites this paper
• Plant-Derived Immunomodulators

  2019cites this paper
• NADPH: Quinone oxidoreductase 1 (NQO1) mediated anti-cancer effects of plumbagin in endocrine resistant MCF7 breast cancer cells.

  2019cites this paper
• Phytoconstituent plumbagin: Chemical, biotechnological and pharmaceutical aspects

  2019cites this paper
• Plumbagin, a natural naphthoquinone, inhibits the growth of esophageal squamous cell carcinoma cells through inactivation of STAT3.

  2018cites this paper
• Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1

  2018cites this paper
• Oxidative stress via inhibition of the mitochondrial electron transport and Nrf-2-mediated anti-oxidative response regulate the cytotoxic activity of plumbagin

  2018cites this paper
• Differential gene expression induced by anti-cancer agent plumbagin is mediated by androgen receptor in prostate cancer cells

  2018cites this paper
• Apigenin exerts anticancer effects on human cervical cancer cells via induction of apoptosis and regulation of Raf/MEK/ERK signalling pathway

  2018cites this paper
• Cucurbitacin D exhibits its anti-cancer effect in human breast cancer cells by inhibiting Stat3 and Akt signaling

  2018cites this paper
• Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling

  2018cites this paper
• Novel triazole analogs of apigenin-7-methyl ether exhibit potent antitumor activity against ovarian carcinoma cells via the induction of mitochondrial-mediated apoptosis

  2018cites this paper
• Plumbagin-Loaded Nanoemulsion Drug Delivery Formulation and Evaluation of Antiproliferative Effect on Prostate Cancer Cells

  2018cites this paper
• Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer

  2018cites this paper
• Plumbagin suppresses chronic periodontitis in rats via down-regulation of TNF-α, IL-1β and IL-6 expression

  2017cites this paper
• Targeting thioredoxin reductase by plumbagin contributes to inducing apoptosis of HL-60 cells.

  2017cites this paper
• Targeting Phenotypic Plasticity in Prostate Cancer

  2017cites this paper
• Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.

  2017cites this paper
• Plumbagin improves the efficacy of androgen deprivation therapy in prostate cancer: A pre‐clinical study

  2017cites this paper
• Vitamin K and its analogs: Potential avenues for prostate cancer management

  2017cites this paper
• Tissue-specific conditional PKCε knockout mice: a model to precisely reveal PKCε functional role in initiation, promotion and progression of cancer

  2016cites this paper
• Chapter 6 Plumbagin and Prostate Cancer Therapy

  2016cites this paper
• Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer

  2016cites this paper
• Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma

  2016cites this paper
• The role of epsilon PKC in acute and chronic diseases: Possible pharmacological implications of its modulators.

  2016cites this paper
• Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells

  2016cites this paper